Abstract
Accurate and expeditious diagnosis and treatment of pulmonary embolism in cancer patients improves patient outcomes. D-dimer is often used to rule out pulmonary embolism. However, this test is less accurate in cancer patients, and it is unclear whether cancer patients with normal D-dimer levels can present with pulmonary embolism. All consecutive patients who presented to The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, between May 2009 and November 2015 who underwent computed tomography pulmonary angiography and plasma D-dimer level measurement were retrospectively reviewed. Patients with suspected pulmonary embolism and normal D-dimer levels were identified. Among the 8023 cancer patients identified, 1156 (14%) had pulmonary embolism. Only 35 patients with pulmonary embolism (3%) had normal plasma D-dimer levels. Twenty-six of these patients had acute pulmonary embolism and the other nine had subacute or chronic pulmonary embolism. Thirteen of the 26 acute cases were in patients with hematological cancer. Most patients (23/35, 66%) had subsegmental or segmental pulmonary embolism. Only one patient had pulmonary embolism in the main pulmonary arteries. Although it is uncommon (3%), cancer patients with radiologic evidence of pulmonary embolism can present with normal D-dimer levels. Recognizing the possibility of this uncommon occurrence is critical in the decision process for ordering diagnostic tests for evaluation of suspected pulmonary embolism.
References
Lee AY, Levine MN (2003) Venous thromboembolism and cancer: risks and outcomes. Circulation 107(23 Suppl 1):I17–21. https://doi.org/10.1161/01.CIR.0000078466.72504.AC
Raja AS, Greenberg JO, Qaseem A, Denberg TD, Fitterman N, Schuur JD, Clinical Guidelines Committee of the American College of P (2015) Evaluation of patients with suspected acute pulmonary embolism: best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 163(9):701–711. https://doi.org/10.7326/M14-1772
Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A (2006) Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 144(3):165–171
Wells PS, Ginsberg JS, Anderson DR, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129(12):997–1005
Lee AY, Julian JA, Levine MN, Weitz JI, Kearon C, Wells PS, Ginsberg JS (1999) Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis. Ann Intern Med 131(6):417–423
Righini M, Le Gal G, De Lucia S, Roy PM, Meyer G, Aujesky D, Bounameaux H, Perrier A (2006) Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost 95(4):715–719
Qdaisat A, Al Soud R, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ (2019) Poor performance of D-Dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica. https://doi.org/10.3324/haematol.2018.211466
Carter BW, Lichtenberger JP 3rd, Wu CC (2014) Acquired abnormalities of the pulmonary arteries. AJR Am J Roentgenol 202(5):W415–421. https://doi.org/10.2214/AJR.13.11760
Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887. https://doi.org/10.1182/blood-2008-06-165845
Righini M, Perrier A, De Moerloose P, Bounameaux H (2008) D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 6(7):1059–1071. https://doi.org/10.1111/j.1538-7836.2008.02981.x
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632–634. https://doi.org/10.1111/j.1538-7836.2007.02374.x
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110(10):2339–2346. https://doi.org/10.1002/cncr.23062
Colombo R, Gallipoli P, Castelli R (2014) Thrombosis and hemostatic abnormalities in hematological malignancies. Clin Lymphoma Myeloma Leuk 14(6):441–450. https://doi.org/10.1016/j.clml.2014.05.003
Siragusa S, Terulla V, Pirrelli S, Porta C, Falaschi F, Anastasio R, Guarnone R, Scarabelli M, Odero A, Bressan MA (2001) A rapid D-dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables. Haematologica 86(8):856–861
Couturaud F, Kearon C, Bates SM, Ginsberg JS (2002) Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy. Blood Coagul Fibrinolysis 13(3):241–246
Schutgens RE, Esseboom EU, Haas FJ, Nieuwenhuis HK, Biesma DH (2002) Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients. Am J Med 112(8):617–621
Acknowledgements
The authors acknowledge Erica Goodoff, ELS, for editorial support.
Author information
Authors and Affiliations
Contributions
S-CJY, AQ, and CCW conceived and designed the study and developed the methods. AQ and CCW acquired data from MD Anderson. CCW reviewed questionable diagnostic images. AQ and CCW analyzed and interpreted the data. AQ created the figures and tables. AQ, CCW, and S-CJY drafted the manuscript. All authors reviewed and provided final approval of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Yeung is the principal investigator of an investigator-initiated clinical trial supported by DepoMed and a retrospective clinical study supported by Bristol-Myers Squibb through ARISTA-USA (BMS/Pfizer American Thrombosis Investigator Initiated Research Program). All other authors declare no competing financial or non-financial interests. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The study was approved by the institutional review boards of MD Anderson; which granted waivers of informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qdaisat, A., Wu, C.C. & Yeung, SC.J. Normal D-dimer levels in cancer patients with radiologic evidence of pulmonary embolism. J Thromb Thrombolysis 48, 174–179 (2019). https://doi.org/10.1007/s11239-019-01863-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-019-01863-4